Dyne Therapeutics stock slips after pricing upsized $375M public offering at $20.50 per share

retained text

Search fieldHome page Seeking Alpha - Power to InvestorsAbout PremiumCreate free accountSearch for Symbols, analysts, keywordsLog in

On the Move

Dyne Therapeutics stock slips after pricing upsized $375M public offering at $20.50 per share

Jul 22, 2026, 2:45 AM ETDyne Therapeutics, Inc. (DYN) StockBy : Meghavi Singh, SA News Editor

SavePlay( 1min )

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search fieldEntering text into the input field will update the search result belowEntering text into the input field will update the search result below

Recommended For You

document fetched 2026-07-22 08:33 · canonical https://seekingalpha.com/news/4616286-dyne-therapeutics-prices-upsized-375m-public-offering-at-2050-per-share?feed_item_type=news